Medtronic announced that the US pivotal trial of its PulseSelect pulsed field ablation system has completed enrollment.
PULSED AF has enrolled 400 patients at 40 sites in the US, Canada, Europe, Australia and Japan. The patients in the trial have symptomatic persistent or paroxysmal atrial fibrillation...